You are adding an alert for:
Compliance for angiogenesis inhibitor treatment with ranibizumab in diabetic macular edema. A seven years experience in Mexican population of the Mexican Institute of Ophthalmology.
You will receive an email whenever this article is corrected, updated, or cited in the literature. You can manage this and all other alerts in My Account
The alert will be sent to: